Xtant Medical (XTNT)
(Real Time Quote from BATS)
$0.50 USD
-0.02 (-3.62%)
Updated Nov 12, 2024 02:32 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
XTNT 0.50 -0.02(-3.62%)
Will XTNT be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for XTNT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for XTNT
Earnings Scheduled For November 12, 2024
Craig-Hallum Reaffirms Their Buy Rating on Xtant Medical Holdings (XTNT)
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference
Earnings To Watch: Xtant Medical Holdings Inc (XTNT) Reports Q3 2024 Result
Xtant Medical Hldgs's Earnings Outlook